For your consideration, the International Union of Microbiological Societies congresses will be held in Montreal from July 27 – August 1st, 2014. This meeting is organized with the Canadian Society of Microbiologists and the National Research Council of Canada, and will include the:

XIV^th International Congress of Bacteriology and Applied Microbiology

XIV^th International Congress of Mycology

XVI^th International Congress of Virology

Further information is available at their external site.

Reporting to the Director of Public Health Laboratory, the Supervisor shall be accountable for the efficient and effective planning, directing, organizing and evaluation of the day-to-day laboratory operations of the Newfoundland Public Health Laboratory to ensure that the objectives of the organization are met.

Duties:

The supervisor provides day-to-day direction to the technical operations of the laboratory as well as functioning as a key member of the PHL Management Team. Management duties include assay verification/validation, incident reporting and corrective actions, develop and track performance indicator, policy and standard operating procedures development and review, laboratory information system team membership, assist in research studies, staff scheduling etc.

To apply for the above position, please forward resume stating qualifications, experience, references and the competition number on or before December 16, 2011.

Poster (PDF download; 118 KB)

We are looking for the most difficult and head-scratching cases for presentation during this interactive session. The audience along with the discussants work through the case trying to solve it. An audience response system will be used.

Please submit your most interesting clinical and laboratory cases for consideration by sending a brief outline of the case (including investigations, diagnosis and treatment) and a short discussion on the instructive value of the case (about 200 words). We like a variety of cases so they can be lengthy and complicated or quick and short – you decide what you think might be of educational value to the audience. These cases will be the basis for discussion of clinical and laboratory diagnosis, clinical management, infection control and other relevant aspects.

If your case is selected, we will work with you to prepare both your slide presentation for the meeting and an abstract of the case (that does not give away the answer) that is suitable for publication in the conference on-line only supplement of the Canadian Journal of Infectious Diseases & Medical Microbiology. Your slide presentation of the case for the meeting will include the clinical presentation, investigations and management, as well as the interactive audience questions.

The deadline for submission of clinical cases is January 24, 2012. Cases must be submitted by email to Dr. Michael Libman, michael.libman@mcgill.ca.

DO NOT SUBMIT THE CASES THROUGH THE REGULAR ABSTRACT SUBMISSION PROCESS.

If your case is accepted for presentation, you will be notified on or around February 15, 2012. You can expect to be involved in presenting and discussing the case during the Clinical Vignettes session, Saturday May 5. Those cases not selected for presentation as a clinical vignette may be accepted for poster presentation as a case report.

If you have any questions, please contact:

Michael Libman – michael.libman@mcgill.ca Tel.: (514) 934-1934 ext 42811

Avez-vous un cas intéressant à partager?

Nous sommes à la recherche des cas les plus difficiles et compliqués aux fins de présentation durant cette séance interactive. L’auditoire et les participants à la discussion travaillent au cas et tentent de le résoudre. Nous utiliserons un système de réponses de l’auditoire.

Veuillez présenter vos cas cliniques et expérimentaux les plus intéressants en envoyant un bref aperçu du cas (dont les investigations, le diagnostic et le traitement) et une courte discussion sur sa valeur instructive (environ 200 mots). Nous souhaitons recevoir une vaste gamme de cas, alors ils peuvent être longs et compliqués ou rapides et courts – à vous de décider ce qui pourrait avoir une valeur éducative pour l’auditoire. Ces cas seront au coeur d’une discussion sur le diagnostic clinique et expérimental, sur la gestion clinique, sur la prévention des infections et sur d’autres aspects pertinents.

Si votre cas est choisi, nous travaillerons avec vous à la préparation du diaporama pour la réunion et d’un abrégé du cas (qui ne donne pas la réponse) pouvant être publié dans le supplément en ligne de la conférence du Journal canadien des maladies infectieuses et de la microbiologie médicale. Votre diaporama sur le cas mis au point pour la réunion comprendra la présentation clinique, les investigations et la gestion, de même que les questions interactives de l’auditoire.

L’échéance de présentation des cas cliniques est le 24 janvier 2012. Les cas doivent être présentés par courriel au Dr Michael Libman (michael.libman@mcgill.ca).

NE PAS PRÉSENTER LES CAS AU MOYEN DU PROCESSUS RÉGULIER DE PRÉSENTATION DES ABRÉGÉS.

Si votre cas est retenu aux fins de présentation, nous vous en informerons le 15 février 2012 ou autour de cette date. Vous pourrez alors vous attendre à participer à la présentation et à la discussion du cas dans la séance des vignettes cliniques, le samedi 5 mai. Les cas qui ne seront pas choisis pour la présentation de vignettes cliniques pourraient être acceptés pour une présentation d’affiches en tant que rapport sur le cas.

Si vous avez des questions, veuillez communiquer avec :

Michael Libman – michael.libman@mcgill.ca Tél. : 514-934-1934, poste 42811

 John Conly Innovation Academy

We are seeking novel and creative strategies that you have developed in any area related to Clinical Medicine, Laboratory Medicine, Infection Prevention and Control, Antimicrobial Stewardship or Public Health.

Tell us about your pioneering approach, radical process improvement, energizing educational program, or transformative quality improvement initiative. Have you started a new program, radically revamped an old one or fundamentally changed the way you do things? Have you developed a new diagnostic assay or invented a new product or device?

Projects for consideration in the Innovation Academy are to be submitted by JANUARY 24, 2012 to the conference secretariat at manager@ammi.ca and flagged for consideration for this unique session. All accepted abstracts will be acknowledged on or around February 15, 2012 and will be presented as POSTERS on Thursday May 3, 2012. Initial judging will take place at this time.

A limited number will be chosen for a 3 minute oral ‘pitch’ followed by 3 minutes of questions during an afternoon session on Friday May 4, 2012. The ‘pitch’ should convey the innovative, creative, and impactful nature of your project. Presentations will be adjudicated based on originality, creativity, applicability, ease of duplication, sustainability and overall significance.

A Prize(s) will be awarded to the winning submission(s). We are looking for those creative programs or changes that you have implemented that may be adapted and used by others to impact quality of life for patients and/or health care providers.

Should you have questions or need more information please contact the conference secretariat at manager@ammi.ca.

We look forward to receiving your submission!

NOUVEAUTÉ pour la Conférence annuelle AMMI Canada – CACMID de 2012

Académie de l’innovation John Conly

Nous sommes à la recherche de stratégies novatrices et créatives que vous avez mises au point dans n’importe quel secteur lié à la médecine clinique, à la médecine de laboratoire, à la prévention et au contrôle des infections, à la gestion des antimicrobiens ou à la santé publique.

Parlez-nous de votre approche de pointe, de l’amélioration radicale d’un processus, de l’énergie insufflée à un programme d’éducation ou d’une initiative d’amélioration de la qualité transformatrice. Avez-vous commencé un nouveau programme, radicalement réorganisé un ancien programme ou changer votre façon de faire de façon fondamentale? Avez-vous mis au point une nouvelle méthode diagnostique ou inventé un nouveau produit ou dispositif?

Les initiatives présentées aux fins d’examen à l’Académie de l’innovation doivent être envoyées au plus tard le 24 JANVIER 2012 au secrétariat de la conférence à manager@ammi.ca et une indication doit préciser qu’elles sont destinées à cette séance unique. Le 15 février 2012 ou autour de cette date, un avis sera envoyé pour tous les abrégés acceptés et ceux-ci seront présentés à titre d’AFFICHES le jeudi 3 mai 2012. C’est alors qu’aura lieu le jugement initial.

Un nombre limité d’abrégés seront choisis pour une présentation orale de trois minutes, suivie d’une période de questions, qui aura lieu durant une séance d’après-midi du vendredi 4 mai 2012. La présentation doit faire ressortir la nature novatrice, créative et riche en répercussions de votre initiative. Les présentations seront jugées selon leur originalité, créativité, applicabilité, facilité de reproduction, viabilité et importance générale.

Un ou des prix seront remis à une ou plusieurs présentations gagnantes. Nous avons hâte de connaître les programmes ou changements créatifs que vous avez mis en place et qui pourraient être adaptés et utilisés par d’autres pour améliorer la qualité de vie des patients ou des fournisseurs de soins de santé.

Si vous avez des questions ou si vous avez besoin d’information, veuillez communiquer avec le secrétariat de la conférence à manager@ammi.ca.

Nous attendons impatiemment la présentation de votre initiative!

AMMI Canada and CACMID would like to invite you to participate in the AMMI Canada – CACMID Annual Conference 2012, to be held in Vancouver,  May 3- 5 at the Sheraton Vancouver Wall Centre Hotel.

The 2012 Annual Conference program is designed to address the needs of health care professionals specializing in the areas of clinical and medical microbiology and infectious diseases: laboratory, clinical (adult and paediatric), public health and infection prevention and control issues.  The program includes a selection of plenary sessions, state to the art clinical lectures, clinical vignettes and presentations, both oral and poster formats. These formats will allow ample opportunity for presentation of innovative scientific research with practical applications on contemporary issues.

 The AMMI Canada – CACMID Annual Conference 2012 plenary topics are:

• Rapidly Evolving Diagnostics: MALDI-TOF MS, Multi pathogen detection and deep sequencing
• Outbreaks: Syphilis, Non-0157 STEC, Measles
• What’s New and What’s Hot?  Adult and Paediatric Infectious Disease and Travel ID

 The AMMI Canada – CACMID Annual Conference 2012 state of the art clinical lecture topics are:

• Microbiota
• Antimicrobial Utilization

NEW for 2012 – the John Conly Innovation Academy

A session dedicated to presenting the newest, most novel and creative strategies developed in any area related to clinical medicine, laboratory medicine, infection prevention and control, antimicrobial stewardship or public health.

I would ask that you please take a moment to review the enclosed Exhibitor Prospectus and consider the value of the benefits outlined. Should you have any questions with regard to Exhibitor opportunities, please do not hesitate in contacting Dianne Comeau at Unconventional Planning for further information. She can be reached by telephone at 613-721-7061, toll free in North America 1-888-625-8455 or via email at Dianne@unconventionalplanning.com.

I hope that you will decide to make a commitment to participate at the AMMI Canada – CACMID Annual Conference 2012. ACT NOW! Space is limited and sells quickly. Don’t miss this opportunity to show your support, to showcase your products and services, and to network with key decision makers in the fields of infectious diseases and medical and clinical microbiology.

Sponsorship opportunities are also available. For more information please contact Mr. Ron Rosenes, at 416-726-5147 or ron@rosenes.com.

DOWNLOADS

2012 AMMI Canada – CACMID Exhibitor Prospectus (PDF Download; 167 Kb)

Exhibit Hall Floor Plan (PDF Download; 51 Kb)

The award is named after Dr. John FitzGerald, a pioneer in the field of Medical Microbiology in Canada. Dr. FitzGerald was born in Drayton, Ontario in 1882. After graduating medical school at the University of Toronto, he studied at the Pasteur Institute in Paris and Brussels. He soon returned to Canada where in 1914, Dr. FitzGerald founded Connaught Laboratories in partnership with the University of Toronto. It was at Connaught Laboratories that Dr. FitzGerald manufactured Canada’s first safe and effective rabies vaccine and diphtheria anti-toxin. Dr. FitzGerald is also regarded as one of the founding fathers of the Laboratory Section meetings of the Canadian Public Health Association that ultimately became the CACMID annual meeting.

It is to Dr. FitzGerald’s extraordinary contributions to Medical Microbiology in Canada that this award is dedicated.

Nominations are Due January 31, 2012.

Nomination Form (Download PDF; 315 kb)

Duties:
The successful applicant will, in conjunction with the laboratory director, provide clinical and technical oversight to appropriate areas of the laboratory in order to enhance laboratory operations and capacity.

- Interpretation and verification of results
- Involvement in policy and SOP preparation
- Responsibility for quality assurance performance within the department
- Responsibility for achieving and maintaining full accreditation with Ontario Laboratory Accreditation ISO 15189, or an equivalent agency
- Business planning, including the assessment and introduction of new methods
- Service as a resource for laboratory staff
- Development and evaluation of diagnostic technologies
- Provincial public health activities
- Support the healthcare professionals and the Department of Health and Community Services regarding laboratory utilization, test selection, result interpretation, and consultation.

To apply for the above position, please forward a resume stating qualifications, experience, references and the competition number, on or before September 30, 2011.

Poster (Download PDF; 25KB)

On behalf of AMMI Canada and CACMID, we invite you to join us in Vancouver from May 3rd to 5th for our annual conference.

The Annual AMMI Canada – CACMID Conference is THE Canadian meeting for physicians, microbiologists, researchers, laboratory technologists, and students in the areas of infectious diseases and medical microbiology. The Program Planning Committee has already had meetings to create a program that will build from the success of previous conferences and the suggestions that our attendees and association members offer. There will be plenary sessions, integrated symposia, oral presentations, poster sessions, exhibits, the clinical vignettes, a trainees’ day, CCM Workshop, QM Seminar and a special lecture. In addition, the Conference will host the meetings of our associated organizations.

Vancouver, surrounded by mountains and ocean, was the first city to rank among the top-ten of the world’s most livable cities for five straight years. A popular tourist destination with countless opportunities for outdoor activities, a thriving art scene, and world-class restaurants representing a variety of international cuisines. It has also been named the Top Tourist Destination in Canada for five straight years! Take advantage of Vancouver’s mild climate to get an early start on summer.

The AMMI Canada – CACMID Annual Conference 2012 in Vancouver will provide you with the latest information in the fields of Infectious Diseases and Microbiology. As importantly, it will provide opportunities to reconnect with old friends and colleagues, and meet new ones.

We encourage you to present your research by submitting abstracts for oral or poster presentation. If you are a student or trainee, there are a number of awards available to you. Build your presentation skills before an always friendly and supportive audience.

We look forward to seeing you in Vancouver in May!

Lynn Johnston

President, AMMI Canada

Gregory Tyrrell

President, CACMID

The 2012 CACMID – AMMI Canada annual conference will be held May 3rd – 5th at the Sheraton Wall Centre in downtown Vancouver! Please check back often as details regarding registration, abstract submission and the scientific program become available!

Click for ONLINE CONFERENCE REGISTRATION!

Hotel Discount: Book Online at the Sheraton Wall Centre and receive $100 off your full conference registration!

Hotel Discount Information: (PDF download; 380 KB)

SUBMIT AN ABSTRACT ** Now Closed **

Call for Abstracts (Download PDF; 1.8 Mb).

Submission Deadline for Abstracts was January 24, 2012.

** NEW ** Nominations are now being accepted for the inaugural John G FitzGerald – CACMID award.

Nominations are Due January 31, 2012. Nomination Form (Download PDF; 315 kb)

** NEW ** The John Conly Innovation Academy:

We are seeking novel and creative strategies that you have developed in any area related to Clinical Medicine, Laboratory Medicine, Infection Prevention and Control, Antimicrobial Stewardship or Public Health. Submission Deadline is January 24, 2012.

Call for Clinical Vignettes

Submission Deadline for Clinical Vignettes is January 24, 2012.

Exhibitors, please view our prospectus for further information on participating at the 2012 meeting in Vancouver.

The ProvLab offers an excellent environment for career development including opportunities to pursue collaborative clinical and research activities with the School of Clinical and Laboratory Medicine, the new Li Ka Shing Institute of Virology, the Divisions of Adult and Pediatric Infectious Disease in the Faculty of Dentistry and Medicine, and the School of Public Health.  The University of Alberta and the University of Calgary rank amongst the top tier of large Canadian research intensive Universities.  Academic appointments may be held in the Faculty of Dentistry and Medicine or the School of Public Health at the University of Alberta or the Faculty of Medicine or School of Public Health at the University of Calgary.

The core functions of the ProvLab include (but are not restricted to):  testing for pathogens or immune states of public health significance, population-based screening, laboratory surveillance to support cluster detection and disease trends of public health significance, specialized diagnostic testing, education, and research.

Deadline:  August 31, 2011 although the position(s) will be held open until filled.

Poster (Download MS Word .doc; 336KB)